Paul Mines Appointed Non-Executive chair
19 October 2021
Lixea announces the appointment of Paul Mines as its Non-Executive Chair.
Through his career, Paul has held a variety of leadership and chair positions with chemical manufacturers, packaging businesses and renewable start-ups. He is currently CEO of Biome Technologies plc, an AIM listed bio-materials focused group.
Read the full press release here.
5 December 2019
Chrysalix, now Lixea, is one of 75 start-ups and SMEs who have been awarded a share of €278 million to accelerate their development. We are absolutely over the moon to receive €2.3 million in order to build our BioFlex pilot plant over the next two years.
IChemE Young Researcher Award
7 November 2019
Lixea is over the moon about CEO and co-founder Dr. Gschwend being awarded the Young Researcher Award for her efforts developing the BioFlex process at the IChemE Global Awards. The award recognises the individual under the age of 30 who best demonstrates the impact of their research in helping to address important economic, environmental or social issues.
The BioFlex project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 836211.
2nd Prize at the EIB Social Innovation Tournament
23 October 2018
At the Social Innovation Tournament held by the European Investment Bank, Lixea (then Chrysalix) wins the second prize in the special category of Circular Economy. We are grateful for the recognition and support that comes with the prize!
21 March 2018
Dr. Gschwend has been awarded a prestigious Royal Academy of Engineering Enterprise Fellowship which will support her for the next 12 months to further develop Lixea (then Chrysalix Technologies) into a sustainable business.
2nd Prize at Climate Impact Battle at Slush
30 November 2017
Climate KIC Venture Competition
18 September 2017
9 June 2017
After the initial proof-of-concept work at the BDC in York, Jason and his team are awarded a Royal Society Translation award to scale-up their process over the next 2 years. Chrysalix (now Lixea) is also awarded the BioBase4SME voucher to carry out work at the BioBase Europe Pilot Plant in Ghent. The work started in September and will be finished in January 2018.
16 January 2017
We are thrilled to hear that Dr. Gschwend was named by Forbes 30 under 30 as one of Europe’s most promising game changers in the field of Science and Healthcare. Read her interview about her journey from the Climate Launchpad Competition in October to the Forbes 30under30 Science and Healthcare list.